Global Animal Medication Industry

NEW YORK, May 26, 2016 /PRNewswire/ -- This report analyzes the worldwide markets for Animal Medication in US$ Million by the following End-Use Segments: Companion Animals, and Farm Animals. The Global market is further analyzed by the following Product Groups: Parasiticides, Vaccines, Anti-Infectives, Medicinal Feed Additives, and Others. The report provides separate comprehensive analytics for the US, Canada, Japan, Europe, Asia-Pacific, Latin America, and Rest of World. Annual estimates and forecasts are provided for the period 2015 through 2022. Also, a six-year historic analysis is provided for these markets. Market data and analytics are derived from primary and secondary research. Company profiles are primarily based on public domain information including company URLs. The report profiles 113 companies including many key and niche players such as -

Bayer HealthCare AG
Boehringer Ingelheim GmbH
Ceva Santé Animale S.A
Dechra Pharmaceuticals PLC
Eli Lilly and Company



Read the full report: http://www.reportlinker.com/p0960410-summary/view-report.html



I. INTRODUCTION, METHODOLOGY & PRODUCT DEFINITIONS

Study Reliability and Reporting Limitations I-1 Disclaimers.............. I-2 Data Interpretation & Reporting Level I-2 Quantitative Techniques & Analytics I-3 Product Definitions and Scope of Study I-3

II. EXECUTIVE SUMMARY

1. MARKET OUTLOOK.............. II-1 Growing Demand for Animal Protein and Rising Pet Ownership Drives Animal Medication Market II-1 Developed Regions Ahead; Developing Markets Gathering Momentum II-2 Farm Animals - The Largest Market Category II-2 Parasiticides Stay in the Lead; Vaccines Drive Growth II-2 Importance of Animal Health: A Prelude II-3

2. MARKET TRENDS & DYNAMICS..............II-5 Growing Pet Ownership and Spending Drives Demand II-5 Table 1: World Pet Dog Ownership (2016E): Top Ten Nations with Dog Population in Millions (includes corresponding Graph/Chart).............. II-5

Table 2: World Pet Cat Ownership (2016E): Top Ten Nations with Cat Population in Millions (includes corresponding Graph/Chart).............. II-6 Companion Animals: A High Value Lucrative Market Segment II-6 Need to Reduce the Foot Print of Food Production Drives Gains II-6 Spread of Zoonotic Diseases Propels Growth II-7 Unmet Animal Health Needs Drives Growth II-7 Need to Ensure Sustainable Food Supply Spurs Growth II-8 Increasing Demand for Animal Protein in Developing Countries to Benefit the Market..............II-8 Opportunity Indicators..............II-9 Table 3: Projected Global Per Capita Consumption of Meat (in kg per year) by Geographic Region by the year 2030 (includes corresponding Graph/Chart)..............II-9

Table 4: Projected Global Consumption of Animal Products (in million tons) by Developing and Developed Countries for the year 2030 (includes corresponding Graph/Chart) II-10 Flavored Veterinary Medications Registers Notable Growth II-10 Safety Concerns: An Opportunity Generator II-11 Healthy Investments in Veterinary Pharmaceuticals Drive Growth II-11 Role of Pharmacokinetics in Animal Drug Development II-12 Animal Health Market Expected to Gain from Antimicrobial Resistance.............. II-12 Responsible use of Animal Medicines Ignites Interest in Herbal Alternatives.............. II-12 Will the Growing Support for Hormone and Antibiotic Free Animal Produce Impact the Growth Prospects of the Animal Medicine?.............. II-12 Growing Momentum for Post Slaughter Strategies Bodes well for Animal Medicine.............. II-13 Demand for Metabolic Modifiers Surging II-13 Genomics to Influence Development of Animal Medicine in the Future.............. II-14 Nanotechnology Fast Gaining Ground in Animal Medicine II-14 Animal Drug Distribution and Dispensing Sees Transformation - A Growing Threat to Veterinarians II-14 Generic Insurgency in Animal Health Market - Not As Strong As in Human Health.............. II-15 Human Drugs Continue to Permeate Animal Drug Market, Manufacturers Queue in to Capitalize on Growing Prospects II-15 Managing a Portfolio of Drugs - Key to Business Risk Aversion II-16 Aquaculture Medicines - A Growing Niche in the Animal Medication Market..............II-17

3. VETERINARY VACCINES MARKET - AN OVERVIEW II-18 Veterinary Vaccine Market on a High Growth Track II-18 Table 5: World Veterinary Vaccines Market (2014): Percentage Breakdown of Dollar Sales of Vaccines by Product Segment - Companion (Canine, Feline) and Livestock (Porcine, Bovine, Poultry, Ovine, Equine and other Animal Vaccines) (includes corresponding Graph/Chart)..............II-19 Veterinary Vaccines Market - Demographic Differences and Market Challenges..............II-19 Recombinant DNA Technology Boosts the Animal Vaccine Industry II-19 Pricing Affects Livestock Medication Market II-21 The Need for Innovative Vaccine Delivery Mechanism Increasing II-21 Egg-Derived Veterinary Vaccines in Human Vaccine Facilities II-21 Will Plant-Derived Vaccines Hold Potential in Animal Health Care Industry?.............. II-22 More Vaccines Needed to Prevent Zoonotic Infections II-22 Parasitic Vaccines Segment Holds Potential II-22 Marker Vaccines Playing a Vital Role in Disease Detection II-23

4. COMPETITIVE LANDSCAPE..............II-24 Zoetis - The Animal Medication Leader II-24 Table 6: Leading Players in the Global Animal Medication Market (2014 & 2015): Annual Sales of Animal Health Products in US$ Million for Bayer, Boehringer Ingelheim, Eli Lilly/Elanco, Merck & Co. / MSD Santé Animale, Merial and Zoetis (includes corresponding Graph/Chart) II-24 Apoquel - A New Blockbuster Drug Strengthening Zoetis' Dermatology Portfolio..............II-25 Market Ripe for Consolidation..............II-25 Boehringer Ingelheim Eyes Business Expansion II-26 Table 7: Boehringer Ingelheim' Leading Animal Medication Drugs (2014): Annual Sales in US$ Million for Duramune, Ingelvac Circoflex, Ingelvac PRRS, Metacam and Vetmedin (includes corresponding Graph/Chart) II-27 Acquisition of Novartis' Animal Health Business Bolsters Elanco's Market Presence..............II-27 New Products Drive Growth in Bayer's Animal Health Segment II-28

5. PRODUCT OVERVIEW.............. II-29 Animal Medication: An Introduction II-29 Preventive Medicines..............II-29 Therapeutic Medicines..............II-29 Others.............. II-29 Considerations.............. II-29 Need for Medications in Companion Animals II-30 Commonly Prescribed (Rx) Animal Health Medications II-30 Non-Prescription Medications..............II-31 Types of Non-Prescription Medications II-32 Types of Animal Medication..............II-32 Pharmaceuticals.............. II-32 Medicinal Feed Additives..............II-32 Biologicals (excluding Vaccines) II-33 Veterinary Vaccines..............II-33 Classification of Veterinary Vaccines II-34 Companion Animals Vaccines..............II-34 Canine Vaccines.............. II-34 Feline Vaccines.............. II-34 Livestock Vaccines..............II-35 A Tabular Analysis on Select Animal Diseases Controlled by Vaccines.............. II-35

6. PRODUCT LAUNCHES/APPROVALS..............II-36 Dechra Veterinary Products to Launch Zycortal in the UK II-36 Zoetis Obtains Conditional License from USDA for Avian Influenza Vaccine..............II-36 Zoetis Rolls Out CLARIFIDE® Plus Genomic Test for Holstein Cattle II-36 Zoetis Obtains FDA Approval for Simparica™ II-36 Merck Animal Health Introduces Safe-Guard® AquaSol for Ascaridia galli Treatment in Chicken II-36 Bionaturis Introduces Five New Developmental Stage Animal Health Biotech Products..............II-36 Merck Animal Health Obtains EC Approval for PORCILIS® PCV ID Vaccine.............. II-37 Bayer Obtains Approval for Claro™ for Treating Otitis Externa in Canines.............. II-37 Boehringer Ingelheim Rolls Out New Swine Vaccines for PRRS in Europe.............. II-37 Merial Launches Tablet Vaccine for NDV Prevention II-37 Bayer Introduces Immunostimulant Zelnate® for Reducing Bovine Respiratory Disease..............II-37 Merck Animal Health Launches INNOVAX®-ILT in EU II-37 Merck Animal Health Rolls Out FORTEGRA® Vaccine in Latin America II-38 Elanco Launches Canine Otitis Externa Treatment Medication - Osurnia®.............. II-38 Ceva Animal Health Rolls Out Canine Heart Failure Management Medication - Libeo.............. II-38 Dechra Veterinary Products Rolls Out 5 ml Bottle Dosage of Comfortan®.............. II-38 Merck Animal Health Launches AQUAVAC® PD3 Vaccine for Salmon II-38 Innovacyn Launches Improved Vetericyn® Plus Medications for Beef Cattle and Dairy..............II-38 Merck Animal Health Rolls Out PORCILIS® PCV M Hyo in Europe II-38 Boehringer Ingelheim Obtains EU Marketing Approval for Bovela® II-38 Ceva Announces US Availability of Tildren® II-39 Zoetis Relaunches Zoamix® Synthetic Anticoccidial II-39 Merck Animal Health Obtains EC Approval of PORCILIS® PCV M Hyo II-39 Merck Animal Health Launches FINADYNE® Transdermal Solution for Reducing Pyrexia and BRD..............II-39 Merck Animal Health Obtains EC Marketing Authorization for NOBILIS® IB Primo QX..............II-39 Merck Animal Health Launches New Fish Vaccine in Asia II-39 Merial Announces Global Launch of PUREVAX® Feline Rabies 3 YR Vaccine.............. II-39 Novartis Rolls Out Florvio for Treating SRD at World Pork Expo II-40 Boehringer Ingelheim Canada Launches Semintra® for Treating Chronic Kidney Disease in Cats..............II-40 Boehringer Ingelheim Rolls Out Cat Vaccine Line - ULTRA™ Fel- O-Vax®.............. II-40 Innovacyn Introduces 4-Ounce Feline Hydrogel II-40 Novartis Launches Strenzen®..............II-40 Eco Animal Health's Aivlosin Receives Marketing Approval II-40

7. RECENT INDUSTRY ACTIVITY..............II-41 Harrisvaccine' RNA Particle Vaccine Platform Obtains USDA Licensure.............. II-41 Ceva Acquires India-based Polchem II-41 Merial and Zoetis Ink Marketing and Distribution Agreement for Dairy Vaccines and Medicines in India II-41 Huvepharma Acquires Zoetis' Longmont Facility II-41 Zydus Cadila Acquires Select Assets of Zoetis in India II-41 Sanofi and Boehringer Ingelheim Ink Business Swap Agreement II-41 Merck Animal Health Receives Conditional License for New Canine Influenza Vaccine..............II-42 Merck Animal Health to Acquire Harrisvaccines II-42 Zoetis Takes Over PHARMAQ..............II-42 Merck Animal Health Announces New Indication for FINADYNE® Transdermal Solution..............II-42 Zoetis Receives Conditional License from USDA for Canine Atopic Dermatitis Immunotherapeutic II-42 Zoetis Obtains Registration for Equivac® HeV from APVMA II-42 Zoetis Completes Expansion at Lincoln, Nebraska-based Facility II-42 Merck Animal Health and China Animal Husbandry Industry ink MoU II-43 Merck Animal Health Registers Two Vaccines in Vietnam II-43 Merial Acquires Equine Products LEGEND® and MARQUIS® from Bayer II-43 Zoetis Acquires Abbott's Animal Health Assets II-43 Dechra Renames Fucithalmic® Vet Eye Medicines as Isathal® II-43 Virbac and Nexvet Ink Development and Marketing Collaboration Agreement for mAb-based Animal Medications II-43 Bayer and DNDi ink Agreement for Developing New Oral Medication to Treat Onchocerciasis II-44 Merial Expands Paulinia Plant Capacity NEXGARD® Production II-44 Novartis Spins Off Animal Health Business II-44 Elanco to Take Over Lohmann Animal Health II-44 Zoetis Reports Shortage of Apoquel Drug II-44 Vétoquinol Acquires Bioniche..............II-44

8. FOCUS ON SELECT GLOBAL PLAYERS..............II-45 Bayer HealthCare AG (Germany)..............II-45 Boehringer Ingelheim GmbH (Germany) II-45 Ceva Santé Animale S.A. (France) II-46 Dechra Pharmaceuticals PLC (UK)..............II-47 Eli Lilly and Company (USA)..............II-47 Merck Animal Health (Netherlands) II-47 Merial (France).............. II-48 Vetericyn, Inc. (USA)..............II-48 Vétoquinol SA (France)..............II-48 Virbac SA (France)..............II-49 Zoetis, Inc. (USA)..............II-49

9. GLOBAL MARKET PERSPECTIVE..............II-50 Table 8: World Recent Past, Current and Future Analysis for Animal Medication Products by Geographic Region/Country - US, Canada, Japan, Europe, Asia-Pacific, Latin America and Rest of World Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2015 through 2022 (includes corresponding Graph/Chart)..............II-50

Table 9: World Historic Review for Animal Medication Products by Geographic Region/Country - US, Canada, Japan, Europe, Asia-Pacific, Latin America and Rest of World Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2009 through 2014 (includes corresponding Graph/Chart).............. II-51

Table 10: World 14-Year Perspective for Animal Medication Products by Geographic Region/Country - Percentage Breakdown of Dollar Sales for US, Canada, Japan, Europe, Asia-Pacific, Latin America and Rest of World Markets for Years 2009, 2016, and 2022 (includes corresponding Graph/Chart) II-52

Table 11: World Recent Past, Current and Future Analysis for Companion Animal Medication Products by Geographic Region/Country - US, Canada, Japan, Europe, Asia-Pacific, Latin America and Rest of World Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2015 through 2022 (includes corresponding Graph/Chart) II-53

Table 12: World Historic Review for Companion Animal Medication Products by Geographic Region/ Country - US, Canada, Japan, Europe, Asia-Pacific, Latin America and Rest of World Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2009 through 2014 (includes corresponding Graph/Chart)..............II-54

Table 13: World 14-Year Perspective for Companion Animal Medication Products by Geographic Region/ Country - Percentage Breakdown of Dollar Sales for US, Canada, Japan, Europe, Asia-Pacific, Latin America and Rest of World Markets for Years 2009, 2016, and 2022 (includes corresponding Graph/Chart).............. II-55

Table 14: World Recent Past, Current and Future Analysis for Farm Animal Medication Products by Geographic Region/Country - US, Canada, Japan, Europe, Asia-Pacific, Latin America and Rest of World Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2015 through 2022 (includes corresponding Graph/Chart)..............II-56

Table 15: World Historic Review for Farm Animal Medication Products by Geographic Region/Country - US, Canada, Japan, Europe, Asia-Pacific, Latin America and Rest of World Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2009 through 2014 (includes corresponding Graph/Chart).............. II-57

Table 16: World 14-Year Perspective for Farm Animal Medication Products by Geographic Region/Country - Percentage Breakdown of Dollar Sales for US, Canada, Japan, Europe, Asia-Pacific, Latin America and Rest of World Markets for Years 2009, 2016, and 2022 (includes corresponding Graph/Chart) II-58

Table 17: World Recent Past, Current and Future Analysis for Animal Medication Products by Farm Animal Type - Cattle, Pigs, and Others Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2015 through 2022 (includes corresponding Graph/Chart)..............II-59

Table 18: World Historic Review for Animal Medication Products by Farm Animal Type - Cattle, Pigs, and Others Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2009 through 2014 (includes corresponding Graph/Chart).............. II-60

Table 19: World 14-Year Perspective for Animal Medication Products by Farm Animal Type - Percentage Breakdown of Dollar Sales for Cattle, Pigs, and Others Markets for Years 2009, 2016, and 2022 (includes corresponding Graph/Chart) II-61

Table 20: World Recent Past, Current and Future Analysis of Animal Medication Products for Cattle by Geographic Region/Country - US, Canada, Japan, Europe, Asia-Pacific, Latin America and Rest of World Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2015 through 2022 (includes corresponding Graph/Chart) II-62

Table 21: World Historic Review of Animal Medication Products for Cattle by Geographic Region/Country - US, Canada, Japan, Europe, Asia-Pacific, Latin America and Rest of World Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2009 through 2014 (includes corresponding Graph/Chart).............. II-63

Table 22: World 14-Year Perspective of Animal Medication Products for Cattle by Geographic Region/Country - Percentage Breakdown of Dollar Sales for US, Canada, Japan, Europe, Asia-Pacific, Latin America and Rest of World Markets for Years 2009, 2016, and 2022 (includes corresponding Graph/Chart).............. II-64

Table 23: World Recent Past, Current and Future Analysis of Animal Medication Products for Pigs by Geographic Region/Country - US, Canada, Japan, Europe, Asia-Pacific, Latin America and Rest of World Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2015 through 2022 (includes corresponding Graph/Chart) II-65

Table 24: World Historic Review of Animal Medication Products for Pigs by Geographic Region/Country - US, Canada, Japan, Europe, Asia-Pacific, Latin America and Rest of World Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2009 through 2014 (includes corresponding Graph/Chart).............. II-66

Table 25: World 14-Year Perspective of Animal Medication Products for Pigs by Geographic Region/Country - Percentage Breakdown of Dollar Sales for US, Canada, Japan, Europe, Asia-Pacific, Latin America and Rest of World Markets for Years 2009, 2016, and 2022 (includes corresponding Graph/Chart).............. II-67

Table 26: World Recent Past, Current and Future Analysis of Animal Medication Products for Other Farm Animals by Geographic Region/Country - US, Canada, Japan, Europe, Asia-Pacific, Latin America and Rest of World Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2015 through 2022 (includes corresponding Graph/Chart).............. II-68

Table 27: World Historic Review of Animal Medication Products for Other Farm Animals by Geographic Region/Country - US, Canada, Japan, Europe, Asia-Pacific, Latin America and Rest of World Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2009 through 2014 (includes corresponding Graph/Chart)..............II-69

Table 28: World 14-Year Perspective of Animal Medication Products for Other Farm Animals by Geographic Region/Country - Percentage Breakdown of Dollar Sales for US, Canada, Japan, Europe, Asia-Pacific, Latin America and Rest of World Markets for Years 2009, 2016, and 2022 (includes corresponding Graph/Chart).............. II-70

Table 29: World Recent Past, Current and Future Analysis for Animal Medication Products by Product Group - Parasiticides, Vaccines, Anti-Infectives, Medicinal Feed Additives and Others Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2015 through 2022 (includes corresponding Graph/Chart)..............II-71

Table 30: World Historic Review for Animal Medication Products by Product Group - Parasiticides, Vaccines, Anti-Infectives, Medicinal Feed Additives and Others Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2009 through 2014 (includes corresponding Graph/Chart) II-72

Table 31: World 14-Year Perspective for Animal Medication Products by Product Group - Percentage Breakdown of Dollar Sales for Parasiticides, Vaccines, Anti-Infectives, Medicinal Feed Additives and Others Markets for Years 2009, 2016, and 2022 (includes corresponding Graph/Chart) II-73

III. MARKET

1. THE UNITED STATES.............. III-1 A.Market Analysis.............. III-1 Current & Future Analysis..............III-1 Food Safety Concerns and Biotechnological Offerings Drive the Veterinary Vaccines Market III-1 Spending on Pets Rises to New Highs, Medications Drive Growth III-1 Table 32: US Expenditure on Pets (2001-2015): Annual Expenditure in US$ Billion (includes corresponding Graph/Chart).............. III-2

Table 33: US Pet Health Market (2015): Percentage Breakdown of Annual Consumer Spending on Pet Health by Type - Food, Live Animal Purchases, Pet Services (Grooming & Boarding), Supplies/OTC Medicine and Vet Care (includes corresponding Graph/Chart).............. III-3 New Channels Emerge Challenging Veterinary Services' Dominance III-3 Table 34: US Pet Medications Market by Distribution Channel (2015): Percentage Breakdown of Sales for Veterinarians, Brick and Mortar Stores and Others (includes corresponding Graph/Chart).............. III-4 Prescription Portability Gains Attention as New Channels Become Popular.............. III-4 Pet Owners Stand to Gain in the Changing Drug Distribution Environment.............. III-5 Significant Hurdles Exist for Generic Pet Medications III-5 Pet Insurance on the Rise..............III-6 Insurance Companies Galvanize Accessibility of Veterinary Innovations.............. III-6 Arsenic-based Animal Medicines Exit US Market, Concerns Remain over Lack of Alternatives III-7 H5N1 Virus: A Conundrum for the US Animal Medication Industry III-7 Regulations.............. III-8 Animal Drug Compounding and the Legalities Behind III-8 FDA's New Draft on Bulk Drug Compounding to Expand Treatment Options.............. III-8 Product Approvals/Launches..............III-9 Strategic Corporate Developments III-11 Key Players.............. III-13 B.Market Analytics..............III-14 Table 35: The US Recent Past, Current and Future Analysis for Animal Medication Products by End-Use Segments - Companion Animals and Farm Animals (Cattle, Pigs and Others) Independently Analyzed with Annual Sales Figures in US$ Million for Years 2015 through 2022 (includes corresponding Graph/Chart).............. III-14

Table 36: The US Historic Review for Animal Medication Products by End-Use Segments - Companion Animals and Farm Animals (Cattle, Pigs and Others) Independently Analyzed with Annual Sales Figures in US$ Million for Years 2009 through 2014 (includes corresponding Graph/Chart) III-15

Table 37: The US 14-Year Perspective for Animal Medication Products by End-Use Segments - Percentage Breakdown of Dollar Sales for Companion Animals and Farm Animals (Cattle, Pigs and Others) for Years 2009, 2016, and 2022 (includes corresponding Graph/Chart)..............III-16

2. CANADA.............. III-17 A.Market Analysis.............. III-17 Current & Future Analysis..............III-17 Overview of the Canadian Animal Health Industry III-17 Imports and Manufacture of Veterinary Biologics III-17 Product Launches..............III-17 B.Market Analytics..............III-18 Table 38: Canadian Recent Past, Current and Future Analysis for Animal Medication Products by End-Use Segments - Companion Animals and Farm Animals (Cattle, Pigs and Others) Independently Analyzed with Annual Sales Figures in US$ Million for Years 2015 through 2022 (includes corresponding Graph/Chart).............. III-18

Table 39: Canadian Historic Review for Animal Medication Products by End-Use Segments - Companion Animals and Farm Animals (Cattle, Pigs and Others) Independently Analyzed with Annual Sales Figures in US$ Million for Years 2009 through 2014 (includes corresponding Graph/Chart) III-19

Table 40: Canadian 14-Year Perspective for Animal Medication Products by End-Use Segments - Percentage Breakdown of Dollar Sales for Companion Animals and Farm Animals (Cattle, Pigs and Others) for Years 2009, 2016, and 2022 (includes corresponding Graph/Chart)..............III-20

3. JAPAN.............. III-21 Market Analysis.............. III-21 Table 41: Japanese Recent Past, Current and Future Analysis for Animal Medication Products by End-Use Segments - Companion Animals and Farm Animals (Cattle, Pigs and Others) Independently Analyzed with Annual Sales Figures in US$ Million for Years 2015 through 2022 (includes corresponding Graph/Chart).............. III-21

Table 42: Japanese Historic Review for Animal Medication Products by End-Use Segments - Companion Animals and Farm Animals (Cattle, Pigs and Others) Independently Analyzed with Annual Sales Figures in US$ Million for Years 2009 through 2014 (includes corresponding Graph/Chart) III-22

Table 43: Japanese 14-Year Perspective for Animal Medication Products by End-Use Segments - Percentage Breakdown of Dollar Sales for Companion Animals and Farm Animals (Cattle, Pigs and Others) for Years 2009, 2016, and 2022 (includes corresponding Graph/Chart)..............III-23

4. EUROPE.............. III-24 A.Market Analysis.............. III-24 Current & Future Analysis..............III-24 Steady Growth Expected for Animal Vaccine Market Due to Superior Livestock Management III-24 New Medicines Continue to Throng European Market III-24 Table 44: EMA Veterinary Medicine Recommendations for Marketing Authorizations (2011-2015): Number of Drugs with Positive Opinions, Negative Opinions and Medicines withdrawn before Opinion (includes corresponding Graph/Chart).............. III-25 New EMA Recommended Drugs for Marketing Authorization by Animal: 2015.............. III-25 Vaccines Make A Mark..............III-26 A Peek into Nature and Indications of EMA- Recommended New Vaccines in 2015..............III-26 Vaccine Regulations..............III-26 EU Animal Welfare Strategy..............III-27 New EU Regulations to Tighten Noose around Prolific Antibiotics Use in Animals..............III-27 Mixed Reactions to Proposed New Law Emerge III-27 EU Focuses on New Regulation for Veterinary Medicines Market III-28 Key Statistical Findings..............III-29 Table 45: European Pet Market (2014): Estimated Pet Population by Type of Pets - Cats, Dogs, Birds, Small Mammals and Aquaria (includes corresponding Graph/Chart) III-29

Table 46: European Antimicrobials Market (2014): Percentage Share Breakdown of Dollar Sales of Antimicrobials by Type - Injectable Forms and Oral Forms (includes corresponding Graph/Chart) III-29 Product Approvals/Launches..............III-30 B.Market Analytics..............III-31 Table 47: European Recent Past, Current and Future Analysis for Animal Medication Products by Geographic Region/Country - France, Germany, Italy, UK, Spain, Russia, and Rest of Europe Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2015 through 2022 (includes corresponding Graph/Chart)..............III-31

Table 48: European Historic Review for Animal Medication Products by Geographic Region/Country - France, Germany, Italy, UK, Spain, Russia, and Rest of Europe Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2009 through 2014 (includes corresponding Graph/Chart).............. III-32

Table 49: European 14-Year Perspective for Animal Medication Products by Geographic Region/Country - Percentage Breakdown of Dollar Sales for France, Germany, Italy, UK, Spain, Russia, and Rest of Europe Markets for Years 2009, 2016, and 2022 (includes corresponding Graph/Chart) III-33

Table 50: European Recent Past, Current and Future Analysis for Animal Medication Products by End-Use Segments - Companion Animals and Farm Animals (Cattle, Pigs and Others) Independently Analyzed with Annual Sales Figures in US$ Million for Years 2015 through 2022 (includes corresponding Graph/Chart).............. III-34

Table 51: European Historic Review for Animal Medication Products by End-Use Segments - Companion Animals and Farm Animals (Cattle, Pigs and Others) Independently Analyzed with Annual Sales Figures in US$ Million for Years 2009 through 2014 (includes corresponding Graph/Chart) III-35

Table 52: European 14-Year Perspective for Animal Medication Products by End-Use Segments - Percentage Breakdown of Dollar Sales for Companion Animals and Farm Animals (Cattle, Pigs and Others) for Years 2009, 2016, and 2022 (includes corresponding Graph/Chart)..............III-36

4a. FRANCE.............. III-37 A.Market Analysis.............. III-37 Current & Future Analysis..............III-37 France - A Leading Nation in Veterinary Medicine R&D III-37 Table 53: French Animal Population (2013): Breakdown of Number of Animals by Type in Millions (includes corresponding Graph/Chart)..............III-37 Product Launches..............III-38 Strategic Corporate Developments III-38 Key Players.............. III-39 B.Market Analytics..............III-41 Table 54: French Recent Past, Current and Future Analysis for Animal Medication Products by End-Use Segments - Companion Animals and Farm Animals (Cattle, Pigs and Others) Independently Analyzed with Annual Sales Figures in US$ Million for Years 2015 through 2022 (includes corresponding Graph/Chart).............. III-41

Table 55: French Historic Review for Animal Medication Products by End-Use Segments - Companion Animals and Farm Animals (Cattle, Pigs and Others) Independently Analyzed with Annual Sales Figures in US$ Million for Years 2009 through 2014 (includes corresponding Graph/Chart) III-42

Table 56: French 14-Year Perspective for Animal Medication Products by End-Use Segments - Percentage Breakdown of Dollar Sales for Companion Animals and Farm Animals (Cattle, Pigs and Others) for Years 2009, 2016, and 2022 (includes corresponding Graph/Chart)..............III-43

4b. GERMANY.............. III-44 A.Market Analysis.............. III-44 Current & Future Analysis..............III-44 Product Launches..............III-44 Strategic Corporate Developments III-44 Key Players.............. III-45 B.Market Analytics..............III-47 Table 57: German Recent Past, Current and Future Analysis for Animal Medication Products by End-Use Segments - Companion Animals and Farm Animals (Cattle, Pigs and Others) Independently Analyzed with Annual Sales Figures in US$ Million for Years 2015 through 2022 (includes corresponding Graph/Chart).............. III-47

Table 58: German Historic Review for Animal Medication Products by End-Use Segments - Companion Animals and Farm Animals (Cattle, Pigs and Others) Independently Analyzed with Annual Sales Figures in US$ Million for Years 2009 through 2014 (includes corresponding Graph/Chart) III-48

Table 59: German 14-Year Perspective for Animal Medication Products by End-Use Segments - Percentage Breakdown of Dollar Sales for Companion Animals and Farm Animals (Cattle, Pigs and Others) for Years 2009, 2016, and 2022 (includes corresponding Graph/Chart)..............III-49

4c. ITALY.............. III-50 Market Analysis.............. III-50 Table 60: Italian Recent Past, Current and Future Analysis for Animal Medication Products by End-Use Segments - Companion Animals and Farm Animals (Cattle, Pigs and Others) Independently Analyzed with Annual Sales Figures in US$ Million for Years 2015 through 2022 (includes corresponding Graph/Chart).............. III-50

Table 61: Italian Historic Review for Animal Medication Products by End-Use Segments - Companion Animals and Farm Animals (Cattle, Pigs and Others) Independently Analyzed with Annual Sales Figures in US$ Million for Years 2009 through 2014 (includes corresponding Graph/Chart) III-51

Table 62: Italian 14-Year Perspective for Animal Medication Products by End-Use Segments - Percentage Breakdown of Dollar Sales for Companion Animals and Farm Animals (Cattle, Pigs and Others) for Years 2009, 2016, and 2022 (includes corresponding Graph/Chart)..............III-52

4d. THE UNITED KINGDOM..............III-53 A.Market Analysis.............. III-53 Current & Future Analysis..............III-53 NOAH - The Regulatory Body behind Animal Medication in the UK III-53 Key Statistics.............. III-54 Table 63: UK Pet Market (2016): Estimated Pet Population (In Million) by Type of Pets - Cats, Dogs, Indoor Fish, Outdoor Fish and Other Pets (includes corresponding Graph/Chart).............. III-54

Table 64: UK Pet Market (2016): Estimated Percentage of Households by Type of Pets (includes corresponding Graph/Chart).............. III-54

Table 65: UK Animal Medication Market by Product Type (2014 & 2015): Percentage Breakdown of Value Sales for Antimicrobials, Anti-inflammatories, Ectoparasiticides, Endoparasiticides, Reproductive Conditions, Vaccines and Others (includes corresponding Graph/Chart) III-55

Table 66: UK Animal Medication Market by End-Segment (2005, 2010 & 2015): Percentage Breakdown of Value Sales for Companion Animals, Food-Producing Animals and Others (includes corresponding Graph/Chart) III-56

Table 67: UK Animal Medication Market by Category (2014 & 2015): Percentage Breakdown of Value Sales for POM-V, POM-VPS and Others (includes corresponding Graph/Chart) III-56 Product Launches..............III-57 Strategic Corporate Development III-57 Dechra Pharmaceuticals Plc - A Key Player III-57 B.Market Analytics..............III-58 Table 68: The UK Recent Past, Current and Future Analysis for Animal Medication Products by End-Use Segments - Companion Animals and Farm Animals (Cattle, Pigs and Others) Independently Analyzed with Annual Sales Figures in US$ Million for Years 2015 through 2022 (includes corresponding Graph/Chart).............. III-58

Table 69: The UK Historic Review for Animal Medication Products by End-Use Segments - Companion Animals and Farm Animals (Cattle, Pigs and Others) Independently Analyzed with Annual Sales Figures in US$ Million for Years 2009 through 2014 (includes corresponding Graph/Chart) III-59

Table 70: The UK 14-Year Perspective for Animal Medication Products by End-Use Segments - Percentage Breakdown of Dollar Sales for Companion Animals and Farm Animals (Cattle, Pigs and Others) for Years 2009, 2016, and 2022 (includes corresponding Graph/Chart)..............III-60

4e. SPAIN.............. III-61 A.Market Analysis.............. III-61 Current & Future Analysis..............III-61 Product Launch.............. III-61 B.Market Analytics..............III-62 Table 71: Spanish Recent Past, Current and Future Analysis for Animal Medication Products by End-Use Segments - Companion Animals and Farm Animals (Cattle, Pigs and Others) Independently Analyzed with Annual Sales Figures in US$ Million for Years 2015 through 2022 (includes corresponding Graph/Chart).............. III-62

Table 72: Spanish Historic Review for Animal Medication Products by End-Use Segments - Companion Animals and Farm Animals (Cattle, Pigs and Others) Independently Analyzed with Annual Sales Figures in US$ Million for Years 2009 through 2014 (includes corresponding Graph/Chart) III-63

Table 73: Spanish 14-Year Perspective for Animal Medication Products by End-Use Segments - Percentage Breakdown of Dollar Sales for Companion Animals and Farm Animals (Cattle, Pigs and Others) for Years 2009, 2016, and 2022 (includes corresponding Graph/Chart)..............III-64

4f. RUSSIA.............. III-65 A.Market Analysis.............. III-65 Current & Future Analysis..............III-65 Russia Mass-Produces Vaccines against Avian Flu III-65 B.Market Analytics..............III-66 Table 74: Russian Recent Past, Current and Future Analysis for Animal Medication Products by End-Use Segments - Companion Animals and Farm Animals (Cattle, Pigs and Others) Independently Analyzed with Annual Sales Figures in US$ Million for Years 2015 through 2022 (includes corresponding Graph/Chart).............. III-66

Table 75: Russian Historic Review for Animal Medication Products by End-Use Segments - Companion Animals and Farm Animals (Cattle, Pigs and Others) Independently Analyzed with Annual Sales Figures in US$ Million for Years 2009 through 2014 (includes corresponding Graph/Chart) III-67

Table 76: Russian 14-Year Perspective for Animal Medication Products by End-Use Segments - Percentage Breakdown of Dollar Sales for Companion Animals and Farm Animals (Cattle, Pigs and Others) for Years 2009, 2016, and 2022 (includes corresponding Graph/Chart)..............III-68

4g. REST OF EUROPE.............. III-69 A.Market Analysis.............. III-69 Current & Future Analysis..............III-69 A Review of Regional Animal Vaccine Markets III-69 The Netherlands..............III-69 Denmark.............. III-69 Product Launch.............. III-71 Merck Animal Health (Netherlands) - A Key Player III-71 B.Market Analytics..............III-72 Table 77: Rest of Europe Recent Past, Current and Future Analysis for Animal Medication Products by End-Use Segments - Companion Animals and Farm Animals (Cattle, Pigs and Others) Independently Analyzed with Annual Sales Figures in US$ Million for Years 2015 through 2022 (includes corresponding Graph/Chart)..............III-72

Table 78: Rest of Europe Historic Review for Animal Medication Products by End-Use Segments - Companion Animals and Farm Animals (Cattle, Pigs and Others) Independently Analyzed with Annual Sales Figures in US$ Million for Years 2009 through 2014 (includes corresponding Graph/Chart) III-73

Table 79: Rest of Europe 14-Year Perspective for Animal Medication Products by End-Use Segments - Percentage Breakdown of Dollar Sales for Companion Animals and Farm Animals (Cattle, Pigs and Others) for Years 2009, 2016, and 2022 (includes corresponding Graph/Chart) III-74

5. ASIA-PACIFIC.............. III-75 A.Market Analysis.............. III-75 Current & Future Analysis..............III-75 Product Launch.............. III-75 B.Market Analytics..............III-76 Table 80: Asia-Pacific Recent Past, Current and Future Analysis for Animal Medication Products by Geographic Region/Country - China, India and Rest of Asia-Pacific Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2015 through 2022 (includes corresponding Graph/Chart)..............III-76

Table 81: Asia-Pacific Historic Review for Animal Medication Products by Geographic Region/Country - China, India and Rest of Asia-Pacific Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2009 through 2014 (includes corresponding Graph/Chart) III-77

Table 82: Asia-Pacific 14-Year Perspective for Animal Medication Products by Geographic Region/Country - Percentage Breakdown of Dollar Sales for China, India and Rest of Asia-Pacific Markets for Years 2009, 2016, and 2022 (includes corresponding Graph/Chart) III-78

Table 83: Asia-Pacific Recent Past, Current and Future Analysis for Animal Medication Products by End-Use Segments - Companion Animals and Farm Animals (Cattle, Pigs and Others) Independently Analyzed with Annual Sales Figures in US$ Million for Years 2015 through 2022 (includes corresponding Graph/Chart)..............III-79

Table 84: Asia-Pacific Historic Review for Animal Medication Products by End-Use Segments - Companion Animals and Farm Animals (Cattle, Pigs and Others) Independently Analyzed with Annual Sales Figures in US$ Million for Years 2009 through 2014 (includes corresponding Graph/Chart) III-80

Table 85: Asia-Pacific 14-Year Perspective for Animal Medication Products by End-Use Segments - Percentage Breakdown of Dollar Sales for Companion Animals and Farm Animals (Cattle, Pigs and Others) for Years 2009, 2016, and 2022 (includes corresponding Graph/Chart) III-81

5a. CHINA.............. III-82 A.Market Analysis.............. III-82 Current & Future Analysis..............III-82 Growing Pet Industry Holds Promise III-82 Increased Livestock Output Lead to Higher Vaccine Demand III-82 Threat of Avian Influenza Outbreaks Creates Market for Effective Vaccine..............III-83 Demand for Higher-Quality Swine Fever Vaccine III-83 Demand for Effective PRRS Vaccines by Foreign Manufacturers III-84 Highly Consolidated Chinese Animal Vaccine Market III-84 Product Launch.............. III-84 B.Market Analytics..............III-85 Table 86: Chinese Recent Past, Current and Future Analysis for Animal Medication Products by End-Use Segments - Companion Animals and Farm Animals (Cattle, Pigs and Others) Independently Analyzed with Annual Sales Figures in US$ Million for Years 2015 through 2022 (includes corresponding Graph/Chart).............. III-85

Table 87: Chinese Historic Review for Animal Medication Products by End-Use Segments - Companion Animals and Farm Animals (Cattle, Pigs and Others) Independently Analyzed with Annual Sales Figures in US$ Million for Years 2009 through 2014 (includes corresponding Graph/Chart) III-86

Table 88: Chinese 14-Year Perspective for Animal Medication Products by End-Use Segments - Percentage Breakdown of Dollar Sales for Companion Animals and Farm Animals (Cattle, Pigs and Others) for Years 2009, 2016, and 2022 (includes corresponding Graph/Chart)..............III-87

5b. INDIA.............. III-88 A.Market Analysis.............. III-88 Current & Future Analysis..............III-88 Animal Vaccination Market Scenario III-88 Major Players.............. III-88 Strategic Corporate Developments III-89 B.Market Analytics..............III-90 Table 89: Indian Recent Past, Current and Future Analysis for Animal Medication Products by End-Use Segments - Companion Animals and Farm Animals (Cattle, Pigs and Others) Independently Analyzed with Annual Sales Figures in US$ Million for Years 2015 through 2022 (includes corresponding Graph/Chart).............. III-90

Table 90: Indian Historic Review for Animal Medication Products by End-Use Segments - Companion Animals and Farm Animals (Cattle, Pigs and Others) Independently Analyzed with Annual Sales Figures in US$ Million for Years 2009 through 2014 (includes corresponding Graph/Chart) III-91

Table 91: Indian 14-Year Perspective for Animal Medication Products by End-Use Segments - Percentage Breakdown of Dollar Sales for Companion Animals and Farm Animals (Cattle, Pigs and Others) for Years 2009, 2016, and 2022 (includes corresponding Graph/Chart)..............III-92

5c. REST OF ASIA-PACIFIC..............III-93 A.Market Analysis.............. III-93 Current & Future Analysis..............III-93 Review of Select Markets..............III-93 Australia.............. III-93 A Note on Australian Veterinary Therapeutics Market III-93 Key Statistical Findings..............III-93 Table 92: Australian Pet Market (2014): Percentage Breakdown of Pet Population by Type of Pets - Dogs, Cats, Fish, Birds and Other Pets (includes corresponding Graph/Chart).............. III-93

Table 93: Australian Pet Healthcare Market (2014): Percentage Share Breakdown of Annual Consumer Expenditure on Pet Health by Service Type (includes corresponding Graph/Chart).............. III-94

Table 94: Australian Pet Healthcare Market (2014): Percentage Share Breakdown of Annual Consumer Expenditure on Veterinary Services by Pet Type - Dogs, Cats and Other Pets (includes corresponding Graph/Chart) III-94

Table 95: Australian Pet Healthcare Market (2014): Percentage Breakdown of Annual Sales of Veterinary Chemicals by Product Type - Parasiticides, Immunotherapy, Nutritional and Metabolism, Antibiotics and Others (includes corresponding Graph/Chart) III-95 Taiwan.............. III-95 Taiwan's Animal Healthcare Industry under Scan III-95 Strategic Corporate Developments III-95 B.Market Analytics..............III-96 Table 96: Rest of Asia-Pacific Recent Past, Current and Future Analysis for Animal Medication Products by End-Use Segments - Companion Animals and Farm Animals (Cattle, Pigs and Others) Independently Analyzed with Annual Sales Figures in US$ Million for Years 2015 through 2022 (includes corresponding Graph/Chart)..............III-96

Table 97: Rest of Asia-Pacific Historic Review for Animal Medication Products by End-Use Segments - Companion Animals and Farm Animals (Cattle, Pigs and Others) Independently Analyzed with Annual Sales Figures in US$ Million for Years 2009 through 2014 (includes corresponding Graph/Chart) III-97

Table 98: Rest of Asia-Pacific 14-Year Perspective for Animal Medication Products by End-Use Segments - Percentage Breakdown of Dollar Sales for Companion Animals and Farm Animals (Cattle, Pigs and Others) for Years 2009, 2016, and 2022 (includes corresponding Graph/Chart) III-98

6. LATIN AMERICA.............. III-99 A.Market Analysis.............. III-99 Current & Future Analysis..............III-99 Product Launch.............. III-99 B.Market Analytics..............III-100 Table 99: Latin American Recent Past, Current and Future Analysis for Animal Medication Products by Geographic Region/Country - Brazil, Mexico and Rest of Latin America Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2015 through 2022 (includes corresponding Graph/Chart)..............III-100

Table 100: Latin American Historic Review for Animal Medication Products by Geographic Region/Country - Brazil, Mexico and Rest of Latin America Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2009 through 2014 (includes corresponding Graph/Chart) III-101

Table 101: Latin American 14-Year Perspective for Animal Medication Products by Geographic Region/Country - Percentage Breakdown of Dollar Sales for Brazil, Mexico and Rest of Latin America Markets for Years 2009, 2016, and 2022 (includes corresponding Graph/Chart) III-102

Table 102: Latin American Recent Past, Current and Future Analysis for Animal Medication Products by End-Use Segments - Companion Animals and Farm Animals (Cattle, Pigs and Others) Independently Analyzed with Annual Sales Figures in US$ Million for Years 2015 through 2022 (includes corresponding Graph/Chart)..............III-103

Table 103: Latin American Historic Review for Animal Medication Products by End-Use Segments - Companion Animals and Farm Animals (Cattle, Pigs and Others) Independently Analyzed with Annual Sales Figures in US$ Million for Years 2009 through 2014 (includes corresponding Graph/Chart) III-104

Table 104: Latin American 14-Year Perspective for Animal Medication Products by End-Use Segments - Percentage Breakdown of Dollar Sales for Companion Animals and Farm Animals (Cattle, Pigs and Others) for Years 2009, 2016, and 2022 (includes corresponding Graph/Chart) III-105

6a. BRAZIL.............. III-106 A.Market Analysis.............. III-106 Current & Future Analysis..............III-106 Strategic Corporate Development III-106 B.Market Analytics..............III-107 Table 105: Brazilian Recent Past, Current and Future Analysis for Animal Medication Products by End-Use Segments - Companion Animals and Farm Animals (Cattle, Pigs and Others) Independently Analyzed with Annual Sales Figures in US$ Million for Years 2015 through 2022 (includes corresponding Graph/Chart)..............III-107

Table 106: Brazilian Historic Review for Animal Medication Products by End-Use Segments - Companion Animals and Farm Animals (Cattle, Pigs and Others) Independently Analyzed with Annual Sales Figures in US$ Million for Years 2009 through 2014 (includes corresponding Graph/Chart) III-108

Table 107: Brazilian 14-Year Perspective for Animal Medication Products by End-Use Segments - Percentage Breakdown of Dollar Sales for Companion Animals and Farm Animals (Cattle, Pigs and Others) for Years 2009, 2016, and 2022 (includes corresponding Graph/Chart) III-109

6b. MEXICO.............. III-110 Market Analysis.............. III-110 Table 108: Mexican Recent Past, Current and Future Analysis for Animal Medication Products by End-Use Segments - Companion Animals and Farm Animals (Cattle, Pigs and Others) Independently Analyzed with Annual Sales Figures in US$ Million for Years 2015 through 2022 (includes corresponding Graph/Chart).............. III-110

Table 109: Mexican Historic Review for Animal Medication Products by End-Use Segments - Companion Animals and Farm Animals (Cattle, Pigs and Others) Independently Analyzed with Annual Sales Figures in US$ Million for Years 2009 through 2014 (includes corresponding Graph/Chart) III-111

Table 110: Mexican 14-Year Perspective for Animal Medication Products by End-Use Segments - Percentage Breakdown of Dollar Sales for Companion Animals and Farm Animals (Cattle, Pigs and Others) for Years 2009, 2016, and 2022 (includes corresponding Graph/Chart)..............III-112

6c. REST OF LATIN AMERICA..............III-113 Market Analysis.............. III-113 Table 111: Rest of Latin American Recent Past, Current and Future Analysis for Animal Medication Products by End-Use Segments - Companion Animals and Farm Animals (Cattle, Pigs and Others) Independently Analyzed with Annual Sales Figures in US$ Million for Years 2015 through 2022 (includes corresponding Graph/Chart)..............III-113

Table 112: Rest of Latin American Historic Review for Animal Medication Products by End-Use Segments - Companion Animals and Farm Animals (Cattle, Pigs and Others) Independently Analyzed with Annual Sales Figures in US$ Million for Years 2009 through 2014 (includes corresponding Graph/Chart) III-114

Table 113: Rest of Latin American 14-Year Perspective for Animal Medication Products by End-Use Segments - Percentage Breakdown of Dollar Sales for Companion Animals and Farm Animals (Cattle, Pigs and Others) for Years 2009, 2016, and 2022 (includes corresponding Graph/Chart) III-115

7. REST OF WORLD.............. III-116 Market Analysis.............. III-116 Table 114: Rest of World Recent Past, Current and Future Analysis for Animal Medication Products by End-Use Segments - Companion Animals and Farm Animals (Cattle, Pigs and Others) Independently Analyzed with Annual Sales Figures in US$ Million for Years 2015 through 2022 (includes corresponding Graph/Chart)..............III-116

Table 115: Rest of World Historic Review for Animal Medication Products by End-Use Segments - Companion Animals and Farm Animals (Cattle, Pigs and Others) Independently Analyzed with Annual Sales Figures in US$ Million for Years 2009 through 2014 (includes corresponding Graph/Chart) III-117

Table 116: Rest of World 14-Year Perspective for Animal Medication Products by End-Use Segments - Percentage Breakdown of Dollar Sales for Companion Animals and Farm Animals (Cattle, Pigs and Others) for Years 2009, 2016, and 2022 (includes corresponding Graph/Chart) III-118

IV. COMPETITIVE LANDSCAPE

Total Companies Profiled: 113 (including Divisions/Subsidiaries - 131)

The United States (54) Canada (2) Japan (1) Europe (41) - France (4) - Germany (6) - The United Kingdom (8) - Italy (2) - Spain (1) - Rest of Europe (20) Asia-Pacific (Excluding Japan) (29) Latin America (1) Middle-East (3)
Read the full report: http://www.reportlinker.com/p0960410-summary/view-report.html

About Reportlinker
ReportLinker is an award-winning market research solution. Reportlinker finds and organizes the latest industry data so you get all the market research you need - instantly, in one place.

http://www.reportlinker.com


__________________________
Contact Clare: [email protected]
US: (339)-368-6001
Intl: +1 339-368-6001

SOURCE Reportlinker

Related Links

http://www.reportlinker.com